US Patent Issued to INTRA-CELLULAR THERAPIES on July 22 for "Methods of treating inflammatory disease" (California, New Jersey Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,364,695, issued on July 22, was assigned to INTRA-CELLULAR THERAPIES INC. (Bedminster, N.J.).

"Methods of treating inflammatory disease" was invented by Peng Li (New Milford, N.J.) and Robert E. Davis (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides the administration of inhibitors of phosphodiesterase 1 (PDE1) for the treatment and prophylaxis of diseases or disorders characterized by inflammation, including methods of treatment and pharmaceutical compositions for use therein."

The patent was filed on June 2, 2021, under Application No. 17/336,798.

*For further information, including images, charts and tables, please ...